Companies / Philippines
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Branded Drugs Under Attack On All Fronts
November 2006 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
The Philippines has adopted a multi-pronged strategy to lower retail drug prices, although the measures have yet to come to fruition. Low-cost generic medicines have been the cornerstone of attempts to improve the affordability of medicines, with a series draft bills attempting to foster the sector by rewriting patent laws, imposing direct price controls and expanding parallel imports from overseas.